Mice lacking phosphatase PP2A subunit PR61/B’δ (Ppp2r5d) develop spatially restricted tauopathy by deregulation of CDK5 and GSK3β
暂无分享,去创建一个
I. Landrieu | G. Lippens | V. Janssens | J. Goris | E. Martens | F. van Leuven | J. Götz | J. Louis | R. Pijnenborg | B. Ledermann | P. Borghgraef | K. Zwaenepoel | Sari Longin | C. Lambrecht | W. Sents | Caroline Lambrecht
[1] C. Phiel,et al. Functions of B56-containing PP2As in major developmental and cancer signaling pathways. , 2010, Life sciences.
[2] S. Strack,et al. Protein phosphatase 2A carboxymethylation and regulatory B subunits differentially regulate mast cell degranulation. , 2010, Cellular signalling.
[3] J. Götz,et al. Animal models reveal role for tau phosphorylation in human disease. , 2010, Biochimica et biophysica acta.
[4] A. Bonci,et al. Protein Phosphatase 2A and Glycogen Synthase Kinase 3 Signaling Modulate Prepulse Inhibition of the Acoustic Startle Response by Altering Cortical M-Type Potassium Channel Activity , 2010, The Journal of Neuroscience.
[5] D. Burgess,et al. PP2A T61 epsilon is an inhibitor of MAP4K3 in nutrient signaling to mTOR. , 2010, Molecular cell.
[6] I. Landrieu,et al. Alzheimer disease specific phosphoepitopes of Tau interfere with assembly of tubulin but not binding to microtubules , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] R. Bernards,et al. Protein phosphatase 2A regulatory subunits and cancer. , 2009, Biochimica et biophysica acta.
[8] S. Strack,et al. The Protein Phosphatase 2A Regulatory Subunits B′β and B′δ Mediate Sustained TrkA Neurotrophin Receptor Autophosphorylation and Neuronal Differentiation , 2008, Molecular and Cellular Biology.
[9] Yigong Shi,et al. Structure of a protein phosphatase 2A holoenzyme: insights into B55-mediated Tau dephosphorylation. , 2008, Molecular cell.
[10] Paul Greengard,et al. A phosphatase cascade by which rewarding stimuli control nucleosomal response , 2008, Nature.
[11] Lili Wang,et al. Interplay between Cyclin-Dependent Kinase 5 and Glycogen Synthase Kinase 3β Mediated by Neuregulin Signaling Leads to Differential Effects on Tau Phosphorylation and Amyloid Precursor Protein Processing , 2008, The Journal of Neuroscience.
[12] V. Janssens,et al. PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail). , 2008, Trends in biochemical sciences.
[13] Anna Kremer,et al. Neurodegeneration and neuroinflammation in cdk5/p25-inducible mice: a model for hippocampal sclerosis and neocortical degeneration. , 2008, The American journal of pathology.
[14] J. Goris,et al. Control of mitotic exit by PP2A regulation of Cdc25C and Cdk1 , 2007, Proceedings of the National Academy of Sciences.
[15] V. Janssens,et al. Selection of Protein Phosphatase 2A Regulatory Subunits Is Mediated by the C Terminus of the Catalytic Subunit* , 2007, Journal of Biological Chemistry.
[16] A. Nairn,et al. Regulation of Protein Phosphatase Inhibitor-1 by Cyclin-dependent Kinase 5* , 2007, Journal of Biological Chemistry.
[17] Angus C Nairn,et al. Protein kinase A activates protein phosphatase 2A by phosphorylation of the B56δ subunit , 2007, Proceedings of the National Academy of Sciences.
[18] W. Hahn,et al. Role for the PP2A/B56delta phosphatase in regulating 14-3-3 release from Cdc25 to control mitosis. , 2006, Cell.
[19] F. Plattner,et al. The Roles of Cyclin-dependent Kinase 5 and Glycogen Synthase Kinase 3 in Tau Hyperphosphorylation* , 2006, Journal of Biological Chemistry.
[20] J. Götz,et al. Altered phosphorylation of cytoskeletal proteins in mutant protein phosphatase 2A transgenic mice. , 2006, Biochemical and biophysical research communications.
[21] L. Petrucelli,et al. HSP induction mediates selective clearance of tau phosphorylated at proline‐directed Ser/Thr sites but not KXGS (MARK) sites , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] H. Paudel,et al. Glycogen synthase kinase 3beta phosphorylates Alzheimer's disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism. , 2006, Biochemistry.
[23] M. Iadarola,et al. Cyclin-dependent kinase 5 activity regulates pain signaling. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[24] F. van Leuven,et al. Changed Conformation of Mutant Tau-P301L Underlies the Moribund Tauopathy, Absent in Progressive, Nonlethal Axonopathy of Tau-4R/2N Transgenic Mice* , 2005, Journal of Biological Chemistry.
[25] C. van Hoof,et al. PP2A: the expected tumor suppressor. , 2005, Current opinion in genetics & development.
[26] G. Johnson,et al. Tau phosphorylation in neuronal cell function and dysfunction , 2004, Journal of Cell Science.
[27] G. Pigino,et al. A novel CDK5‐dependent pathway for regulating GSK3 activity and kinesin‐driven motility in neurons , 2004, The EMBO journal.
[28] S. Speciale,et al. Altered Expression Levels of the Protein Phosphatase 2A ABαC Enzyme Are Associated with Alzheimer Disease Pathology , 2004, Journal of neuropathology and experimental neurology.
[29] J. Vermeesch,et al. Genomic organisation, chromosomal localisation tissue distribution and developmental regulation of the PR61/B' regulatory subunits of protein phosphatase 2A in mice. , 2004, Journal of molecular biology.
[30] R. DePinho,et al. Decreased Cyclin-Dependent Kinase 5 (cdk5) Activity Is Accompanied by Redistribution of cdk5 and Cytoskeletal Proteins and Increased Cytoskeletal Protein Phosphorylation in p35 Null Mice , 2003, The Journal of Neuroscience.
[31] V. Centonze,et al. PKA, PKC, and the protein phosphatase 2A influence HAND factor function: a mechanism for tissue-specific transcriptional regulation. , 2003, Molecular cell.
[32] R. Nitsch,et al. Diversity, developmental regulation and distribution of murine PR55/B subunits of protein phosphatase 2A , 2002, The European journal of neuroscience.
[33] H. Soininen,et al. Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35. , 2002, Brain research. Molecular brain research.
[34] Qing Tian,et al. Role of Serine/Threonine Protein Phosphatase in Alzheimer’s Disease , 2002, Neurosignals.
[35] R. Nitsch,et al. Reduced protein phosphatase 2A activity induces hyperphosphorylation and altered compartmentalization of tau in transgenic mice. , 2001, The Journal of biological chemistry.
[36] R. Nitsch,et al. Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils , 2001, Science.
[37] J. Trojanowski,et al. PP2A mRNA Expression Is Quantitatively Decreased in Alzheimer's Disease Hippocampus , 2001, Experimental Neurology.
[38] René Hen,et al. Decreased nuclear β‐catenin, tau hyperphosphorylation and neurodegeneration in GSK‐3β conditional transgenic mice , 2001 .
[39] R. Hen,et al. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. , 2001, The EMBO journal.
[40] M. Mercken,et al. Glycogen Synthase Kinase-3β Phosphorylates Protein Tau and Rescues the Axonopathy in the Central Nervous System of Human Four-repeat Tau Transgenic Mice* , 2000, The Journal of Biological Chemistry.
[41] P. Davies,et al. Conformational change as one of the earliest alterations of tau in Alzheimer’s disease , 2000, Neurobiology of Aging.
[42] L. Tsai,et al. Neurotoxicity induces cleavage of p35 to p25 by calpain , 2000, Nature.
[43] H. Geerts,et al. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. , 1999, The American journal of pathology.
[44] G. Bloom,et al. Molecular Interactions among Protein Phosphatase 2A, Tau, and Microtubules , 1999, The Journal of Biological Chemistry.
[45] K. Ishiguro,et al. Okadaic acid-stimulated degradation of p35, an activator of CDK5, by proteasome in cultured neurons. , 1998, Biochemical and biophysical research communications.
[46] B. Hemmings,et al. Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Calpha. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[47] L. Tsai,et al. p35, the Neuronal-specific Activator of Cyclin-dependent Kinase 5 (Cdk5) Is Degraded by the Ubiquitin-Proteasome Pathway* , 1998, The Journal of Biological Chemistry.
[48] F. Ebner,et al. Brain protein phosphatase 2A: Developmental regulation and distinct cellular and subcellular localization by B subunits , 1998, The Journal of comparative neurology.
[49] G. Jicha,et al. Alz‐50 and MC‐1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau , 1997, Journal of neuroscience research.
[50] G. Bloom,et al. Regulation of the Phosphorylation State and Microtubule-Binding Activity of Tau by Protein Phosphatase 2A , 1996, Neuron.
[51] Veeranna,et al. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[52] D. Virshup,et al. The B56 Family of Protein Phosphatase 2A (PP2A) Regulatory Subunits Encodes Differentiation-induced Phosphoproteins That Target PP2A to Both Nucleus and Cytoplasm* , 1996, The Journal of Biological Chemistry.
[53] E. Mandelkow,et al. Dephosphorylation of tau protein and Alzheimer paired helical filaments by calcmeurin and phosphatase‐2A , 1993, FEBS letters.
[54] W. Merlevede,et al. A specific immunoprecipitation assay for the protein kinase FA/glycogen synthase kinase 3. , 1993, Analytical biochemistry.
[55] P. Cohen,et al. p42 map kinase phosphorylation sites in microtubule‐associated protein tau are dephosphorylated by protein phosphatase 2A1 Implications for Alzheimer's disease , 1992, FEBS letters.
[56] P. Agostinis,et al. Specificity of the polycation-stimulated (type-2A) and ATP,Mg-dependent (type-1) protein phosphatases toward substrates phosphorylated by P34cdc2 kinase. , 1992, European journal of biochemistry.
[57] W. Merlevede,et al. Purification and properties of polycation-stimulated phosphorylase phosphatases from rabbit skeletal muscle. , 1987, The Journal of biological chemistry.